Literature DB >> 4007420

Biliary lipid output and bile acid kinetics in cholesterol gallstone disease. Evidence for an increased hepatic secretion of cholesterol in Swedish patients.

K Nilsell, B Angelin, L Liljeqvist, K Einarsson.   

Abstract

Sweden has one of the highest incidences of gallstone disease in the Western world. It is therefore important to characterize the mechanisms responsible for the formation of cholesterol gallstones in this population. In the present study, we have determined the kinetics of the two primary bile acids, cholic acid and chenodeoxycholic acid, and the hepatic secretion rates of the biliary lipids in 21 normolipidemic, nonobese gallstone patients (13 with functioning and 8 with nonfunctioning gallbladder) and in 23 healthy controls. The cholesterol saturation of fasting gallbladder bile averaged 110% in the gallstone patients with functioning gallbladder and 82% in the controls. The pool sizes of cholic acid and chenodeoxycholic acid were reduced by about 40% in the two groups of gallstone patients, whereas the rates of synthesis were close to normal. The fractional catabolic rate of both bile acids was increased in both groups of gallstone patients. The gallstone patients with functioning gallbladder had an increased (about 50%) cholesterol secretion but normal bile acid and phospholipid secretion rates. In the gallstone patients with nonfunctioning gallbladder the secretion rates of biliary lipids were not significantly different from those of the controls. The ratio between cholesterol and bile acids was about 50% higher in the gallstone patients with functioning gallbladder than in the controls or in those with nonfunctioning gallbladder. The results indicate that the hepatic secretion of cholesterol is an important determinant for the development of saturated gallbladder bile in Swedish gallstone patients.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4007420     DOI: 10.1016/0016-5085(85)90328-2

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  14 in total

1.  Biliary lipid composition in cholesterol microlithiasis.

Authors:  M Fracchia; S Pellegrino; P Secreto; L Gallo; G Masoero; A Pera; G Galatola
Journal:  Gut       Date:  2001-05       Impact factor: 23.059

Review 2.  Deoxycholic acid and the pathogenesis of gall stones.

Authors:  S N Marcus; K W Heaton
Journal:  Gut       Date:  1988-04       Impact factor: 23.059

Review 3.  An overview on possible links between aflatoxin B1 exposure and gallbladder cancer.

Authors:  Jéssica Costa; Nelson Lima; Cledir Santos
Journal:  Mycotoxin Res       Date:  2021-05-21       Impact factor: 3.833

4.  Regulation of biliary cholesterol secretion. Functional relationship between the canalicular and sinusoidal cholesterol secretory pathways in the rat.

Authors:  F Nervi; I Marinović; A Rigotti; N Ulloa
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

5.  Modulation of intrahepatic cholesterol trafficking: evidence by in vivo antisense treatment for the involvement of sterol carrier protein-2 in newly synthesized cholesterol transport into rat bile.

Authors:  L Puglielli; A Rigotti; L Amigo; L Nuñez; A V Greco; M J Santos; F Nervi
Journal:  Biochem J       Date:  1996-08-01       Impact factor: 3.857

6.  Altered migrating myoelectrical complex in an animal model of cholesterol gallstone disease: the effect of erythromycin.

Authors:  Q W Xu; R B Scott; D T Tan; E A Shaffer
Journal:  Gut       Date:  1998-12       Impact factor: 23.059

7.  Disorders of bile acid metabolism in cholesterol gallstone disease.

Authors:  F Berr; E Pratschke; S Fischer; G Paumgartner
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

8.  Increased bile acid concentration in liver tissue with cholesterol gallstone disease.

Authors:  A Honda; T Yoshida; N Tanaka; Y Matsuzaki; B He; J Shoda; T Osuga
Journal:  J Gastroenterol       Date:  1995-02       Impact factor: 7.527

9.  Hepatic cholesterol and bile acid synthesis in Japanese patients with cholesterol gallstones.

Authors:  A Honda; T Yoshida; N Tanaka; Y Matsuzaki; B He; T Osuga; N Kobayashi; K Ozawa
Journal:  Gastroenterol Jpn       Date:  1993-06

10.  Nucleation time of gall bladder bile in gall stone patients: influence of bile acid treatment.

Authors:  S Sahlin; J Ahlberg; B Angelin; E Reihnér; K Einarsson
Journal:  Gut       Date:  1991-12       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.